Hydrochloric Acid

Hydrochloric Acid

SCHEMBL440810

C=CC(NCCC(CCN)[Si](OC)(OC)OC)c1ccccc1.Cl

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 known ✓ P35367 2/20 0.34
HTR1A known ✓ P08908 2/20 0.33
SLC6A2 known ✓ P23975 2/20 0.33
SLC6A4 known ✓ P31645 2/20 0.33
ADRA1A known ✓ P35348 2/20 0.33
OPRM1 known ✓ P35372 2/20 0.33
DRD3 known ✓ P35462 2/20 0.33
SLC6A3 known ✓ Q01959 2/20 0.33
KCNH2 known ✓ Q12809 2/20 0.33
CHRM2 known ✓ P08172 1/20 0.33
ADRA2A known ✓ P08913 1/20 0.33
CHRM1 known ✓ P11229 1/20 0.33
DRD1 known ✓ P21728 1/20 0.33
CASR known ✓ P41180 1/20 0.33
HTR2B known ✓ P41595 1/20 0.33
OPRK1 known ✓ P41145 2/20 0.31
OPRD1 known ✓ P41143 1/20 0.31
ADRB2 known ✓ P07550 1/20 0.30
ADRB1 known ✓ P08588 1/20 0.30
DRD2 known ✓ P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL98709 0.99 HRH1 (0.35) KMT2AALDH1A1CYP3A4MEN1HTT
Acetic Acid SCHEMBL17976608 0.93 MTNR1A (0.34) KMT2AALDH1A1CYP3A4MEN1ALOX15
SCHEMBL28997495 0.88 CYP3A4 (0.35) KMT2AALDH1A1CYP3A4MEN1HTT
SCHEMBL1191989 0.87 SLC6A2 (0.33) KMT2AALDH1A1CYP3A4MEN1HTT
SCHEMBL29035497 0.84 CYP3A4 (0.35) KMT2AALDH1A1CYP3A4MEN1HTT
SCHEMBL29034971 0.81 HRH1 (0.35) ALDH1A1HRH1SLC6A2HTR2A
Hydrochloric Acid SCHEMBL9769539 0.77 CYP3A4 (0.42) KMT2AALDH1A1CYP3A4MEN1HTT
SCHEMBL28174803 0.75 HRH1 (0.41) KMT2AALDH1A1CYP3A4MEN1HTT
Hydrochloric Acid SCHEMBL11969894 0.75 HRH1 (0.33) HRH1
SCHEMBL7783746 0.74 MTOR (0.34) ALDH1A1CYP3A4HTTALOX15SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 952 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260106321-A1 SEPARATOR FOR ELECTROCHEMICAL DEVICE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME LG ENERGY SOLUTION, LTD. (KR) 2026-04-16 US claimed
US-20250154325-A1 VANILLIC ACID-BASED ORGANIC-INORGANIC COMPOUND, CURABLE COMPOSITION, AND PRODUCTION METHOD THEREOF ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2025-05-15 US claimed
US-12107198-B2 Barrier film and method for manufacturing the same, wavelength conversion sheet and method for manufacturing the same, and optical laminate and method for manufacturing the same TOPPAN PRINTING CO., LTD. (JP) 2024-10-01 US claimed
WO-2024196181-A1 SOLID LIPID PARTICLE COMPRISING CONJUGATE OF PURE VITAMIN C AND CATIONIC METAL-AMINO CLAY AND METHOD FOR PREPARING SAME 가천대학교 산학협력단 2024-09-26 WO claimed
CN-117186407-A Organic-inorganic composite, method for preparing the same, and curable composition comprising the same 韩国电子通信研究院 2023-12-08 CN claimed
WO-2023096046-A1 POLYPROPYLENE RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED PRODUCTS COMPRISING SAME 주식회사 코프라 2023-06-01 WO claimed
US-11655118-B2 Film roll and film bundle TOYOBO CO., LTD. (JP) 2023-05-23 US claimed
EP-3775023-B1 A POLYAMIDE COMPOSITION, MANUFACTURING METHOD, AN APPLICATION AND ARTICLE THEREOF BASF SE (DE) 2023-05-10 EP claimed
EP-4094750-A2 ORGANIC-INORGANIC COMPOSITE POWDER AND COMPOSITION INCLUDING THE SAME Amorepacific Corporation (KR) 2022-11-30 EP claimed
US-20220347061-A1 ORGANIC-INORGANIC COMPOSITE POWDER AND COMPOSITION INCLUDING THE SAME AMOREPACIFIC CORPORATION (KR) 2022-11-03 US claimed
US-20170313847-A1 TIRE BRIDGESTONE CORPORATION (JP) 2017-11-02 US claimed
US-8406663-B2 Developing roller for electrophotographic image forming apparatus, and manufacturing method of the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2013-03-26 US claimed
US-8202932-B2 Alkylated borohydride or tetraalkyl borane metal or ammonium salt and a polymerizable (meth)acrylated siloxane, low energy bonding surface, for example, the polyolefins, polyethylene, and polypropylene LOCTITE (R&D) LIMITED (IE) 2012-06-19 US claimed
US-20120061659-A1 ORGANIC PHOTOELECTRIC CONVERSION ELEMENT SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-15 US claimed
US-20110110690-A1 DEVELOPING ROLLER FOR ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS, AND MANUFACTURING METHOD OF THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-05-12 US claimed
US-20100272991-A1 CHROME-FREE COATING COMPOSITIONS FOR SURFACE-TREATING STEEL SHEET INCLUDING CARBON NANOTUBE, METHODS FOR SURFACE-TREATING STEEL SHEET AND SURFACE-TREATED STEEL SHEETS USING THE SAME POSCO (KR) 2010-10-28 US claimed
EP-2240627-A2 CHROME-FREE COATING COMPOSITIONS FOR SURFACE-TREATING STEEL SHEET INCLUDING CARBON NANOTUBE, METHODS FOR SURFACE-TREATING STEEL SHEET AND SURFACE-TREATED STEEL SHEETS USING THE SAME Posco (KR) 2010-10-20 EP claimed
US-20100116179-A1 Polyurethane composite matrix material and composite thereof ADVANCED BUILDING COMPOSITES, LLC 2010-05-13 US claimed
WO-2009084849-A2 CHROME-FREE COATING COMPOSITIONS FOR SURFACE-TREATING STEEL SHEET INCLUDING CARBON NANOTUBE, METHODS FOR SURFACE-TREATING STEEL SHEET AND SURFACE-TREATED STEEL SHEETS USING THE SAME POSCO (KR) 2009-07-09 WO claimed
US-20060122319-A1 Adhesive bonding systems having adherence to low energy surfaces LOCTITE (R&D) LIMITED 2006-06-08 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260106321-A1 SEPARATOR FOR ELECTROCHEMICAL DEVICE AND ELECTROCHEMICAL DEVICE INCLUDING THE SAME ZW10, ILK, PIEZO1 HRH1 4604/4885HTR1A 3454/4885SLC6A2 2729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.